The HarbourVest Boston Team

Jackie Peradotto



About Jackie

Jackie Peradotto joined HarbourVest in 2009. She left the Firm to attend business school and rejoined HarbourVest’s direct investment team in 2014 after completing her MBA. Jackie focuses on sourcing, reviewing, executing, and monitoring direct co-investments, primarily in the healthcare industry. She serves as a board member at Comprehensive Pharmacy Services (CPS) and Dentistry for Children (D4C), and formerly served as a board member of Five Star Food Service. Jackie has played a key role on several deals including Advance Health, Aldevron, Cambrex, CareCentrix, MedOptions, MultiPlan, Press Ganey, and Vetsource.

Jackie’s previous experience includes three years with Morgan Stanley, where she was an investment banking analyst in the Global Power & Utility Group in New York and the Corporate Finance Group in San Francisco. Her prior experience also includes a position at McKesson Corporation.

She received an AB in Molecular Biology from Princeton University in 2006 and an MBA in Health Care Management (with honors) from the Wharton School at the University of Pennsylvania in 2014.

Continuation solutions encompass a host of transaction types in which a GP secures interim liquidity and/or additional primary capital for their LPs in a strongly performing asset, or set of assets, that the GP will continue to own and control. Specifically, they include continuation funds, new funds created by GPs for the purpose of acquiring the asset(s) that continue to be managed by the same GP and capitalized by one or several secondary buyers, or equity recapitalizations involving a direct equity or structured equity investment into a portfolio company. These transactions can also include a parallel investment from the GP’s latest fund into that same pool of assets (a “cross-fund trade”).